Serrumab: a human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venon (2012)
- Authors:
- USP affiliated authors: FACCIOLI, LUCIA HELENA - FCFRP ; BARBOSA, JOSE ELPIDIO - FMRP ; BRAGA, ELIANE CANDIANI ARANTES - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.3109/1547691X.2011.649220
- Subjects: VENENOS DE ORIGEM ANIMAL; ESCORPIÕES; ANTICORPOS MONOCLONAIS; CITOCINAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Immunotoxicology
- ISSN: 1547-691X
- Volume/Número/Paginação/Ano: v. 9, n. 2, p. 173-183, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: other-oa
-
ABNT
PUCCA, Manuela Berto et al. Serrumab: a human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venon. Journal of Immunotoxicology, v. 9, n. 2, p. 173-183, 2012Tradução . . Disponível em: https://doi.org/10.3109/1547691X.2011.649220. Acesso em: 29 dez. 2025. -
APA
Pucca, M. B., Zoccal, K. F., Roncolato, E. C., Bertolini, T. B., Campos, L. B., Cologna, C. T., et al. (2012). Serrumab: a human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venon. Journal of Immunotoxicology, 9( 2), 173-183. doi:10.3109/1547691X.2011.649220 -
NLM
Pucca MB, Zoccal KF, Roncolato EC, Bertolini TB, Campos LB, Cologna CT, Faccioli LH, Arantes EC, Barbosa JE. Serrumab: a human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venon [Internet]. Journal of Immunotoxicology. 2012 ; 9( 2): 173-183.[citado 2025 dez. 29 ] Available from: https://doi.org/10.3109/1547691X.2011.649220 -
Vancouver
Pucca MB, Zoccal KF, Roncolato EC, Bertolini TB, Campos LB, Cologna CT, Faccioli LH, Arantes EC, Barbosa JE. Serrumab: a human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venon [Internet]. Journal of Immunotoxicology. 2012 ; 9( 2): 173-183.[citado 2025 dez. 29 ] Available from: https://doi.org/10.3109/1547691X.2011.649220 - Human antibody fragments (scFv 2A) inhibit biochemical and immunological effects of Tityus serrulatus venon
- Serrumab's multiple neutralizing capacities to scorpion toxins
- Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities
- A human antibody fragment specific to Tityus serrulatus Ts1 major toxin recognizes other potential sodium channel toxins and could be used as a new ativenom
- Human antibody fragments inhibit the action of TsTx-I toxin in vitro and the lethality of the Tityus serrulatus venom in vivo
- Human antibody fragments (scFv) produced by phage display technology recognize Tityus serrulatus venom and inhibit the action of TsTx-1 toxin on 'Na POT.+' channels
- Inflammatory reaction induced by Tityus serrulatus venom and TsTX-I in mice
- Inflammatory reaction induced by Tityus serrulatus venom and TsTX-I in mice
- Expanding biological activities of Ts19 Frag-II toxin: insights into IL-17 production
- Peptide 1956 induces selectively mononuclear cells recruitment to bronchoalveolar space
Informações sobre o DOI: 10.3109/1547691X.2011.649220 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
